SCA
BEAT

Secor Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Secor Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-44,984
Closed -$1.48M – 644
2017
Q3 		$1.48M Buy
+44,984
New +$1.56M 0.14% 221
2016
Q4 		– Sell
-107,458
Closed -$2M – 713
2016
Q3 		$2M Buy
107,458
+23,359
+28% +$441K 0.22% 146
2016
Q2 		$1.37M Buy
+84,099
New +$1.24M 0.17% 193

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Secor Capital Advisors's BEAT Position: Q4 2017 in Review

Secor Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 44,984 shares — an estimated $1.48M sold.

Secor Capital Advisors first reported a position in BEAT in Q2 2016 and held it in 3 quarters. The position peaked at $2M in Q3 2016. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

  • Secor Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 44,984 BioTelemetry, Inc. shares in Q4 2017, an estimated $1.48M.
  • Secor Capital Advisors first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 3 quarters.
  • Secor Capital Advisors's BioTelemetry, Inc. position peaked at $2M in Q3 2016.
  • 192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on Secor Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.